Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers [Forbes]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Forbes
For a pancreatic tumor situated close to vital organs, or a cancer embedded deep within the brain, drug developers have always faced a critical dilemma – even if a drug is capable of eradicating the tumor, how do you deliver it in a sufficiently high dose without causing irreversible harm? Enter radionuclide therapy, a class of cancer medicines which deliver radioactive atoms or radionuclides, to tumors deep inside the body with extreme precision. This idea originates from the 1940s when doctors began using radioactive iodine as a novel treatment for thyroid cancer due to iodine being preferentially absorbed by the tumor cells. The past 13 years have seen a growing number of regulatory approvals, beginning with Xofigo, a therapy aimed at patients with advanced, treatment-resistant prostate cancer which has spread to the bones. The market for this class of cancer medicines is now rapidly growing and is projected to be worth $10.7 billion by 2030. The development of these treat
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies [MSNBC.com]MSNBC.com
- UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies [CNBC]CNBC
- Novartis AG (NVS) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amidst Core Income ... [Yahoo! Finance]Yahoo! Finance
- Novartis Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Novartis Adds New Therapies As Shares Trade Below Analyst Value Targets [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 4/28/26 - Miss
NVS
Sec Filings
- 4/28/26 - Form 6-K
- 3/18/26 - Form 6-K
- 3/17/26 - Form FWP
- NVS's page on the SEC website